An overview of precision oncology basket and umbrella trials for clinicians
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An overview of precision oncology basket and umbrella trials for clinicians
Authors
Keywords
-
Journal
CA-A CANCER JOURNAL FOR CLINICIANS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-02-07
DOI
10.3322/caac.21600
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FDA Approval Summary: Pembrolizumab for the treatment of microsatellite instability-high solid tumors
- (2019) Leigh Marcus et al. CLINICAL CANCER RESEARCH
- Finding driver mutations in cancer: Elucidating the role of background mutational processes
- (2019) Anna-Leigh Brown et al. PLoS Computational Biology
- RoB 2: a revised tool for assessing risk of bias in randomised trials
- (2019) Jonathan A C Sterne et al. BMJ-British Medical Journal
- Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols
- (2019) Jay J. H Park et al. Trials
- Update on the types and usage of liquid biopsies in the clinical setting: a systematic review
- (2018) Borros Arneth BMC CANCER
- Clinical trials recruitment planning: A proposed framework from the Clinical Trials Transformation Initiative
- (2018) Grant D. Huang et al. Contemporary Clinical Trials
- Master protocols in lung cancer
- (2018) Vincent K. Lam et al. CURRENT OPINION IN ONCOLOGY
- Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial
- (2018) Bob T. Li et al. JOURNAL OF CLINICAL ONCOLOGY
- Basket trial of TRK inhibitors demonstrates efficacy in TRK fusion-positive cancers
- (2018) Yu Chen et al. Journal of Hematology & Oncology
- Precision oncology in the age of integrative genomics
- (2018) Chandan Kumar-Sinha et al. NATURE BIOTECHNOLOGY
- Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes
- (2018) Fabrizio De Benedetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
- (2018) Alexander Drilon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vemurafenib for BRAF V600–Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis
- (2018) Eli L. Diamond et al. JAMA Oncology
- A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers.
- (2018) Bob T. Li et al. JOURNAL OF CLINICAL ONCOLOGY
- EA5142 adjuvant nivolumab in resected lung cancers (ANVIL).
- (2018) Jamie E. Chaft et al. JOURNAL OF CLINICAL ONCOLOGY
- Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both
- (2017) Janet Woodcock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Blockade of HLA Antibody-Triggered Classical Complement Activation in Sera From Subjects Dosed With the Anti-C1s Monoclonal Antibody TNT009—Results from a Randomized First-in-Human Phase 1 Trial
- (2017) Jakob Mühlbacher et al. TRANSPLANTATION
- Statistical controversies in clinical research: basket trials, umbrella trials, and other master protocols: a review and examples
- (2016) L. A. Renfro et al. ANNALS OF ONCOLOGY
- Is the NCI MATCH trial a match for gynecologic oncology?
- (2016) Kathleen N. Moore et al. GYNECOLOGIC ONCOLOGY
- Analytical Validation and Application of a Targeted Next-Generation Sequencing Mutation-Detection Assay for Use in Treatment Assignment in the NCI-MPACT Trial
- (2016) Chih-Jian Lih et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Towards precision medicine
- (2016) Euan A. Ashley NATURE REVIEWS GENETICS
- Core Concept: Basket trial approach capitalizes on the molecular mechanisms of tumors
- (2016) Stephen Ornes PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- Tissue requirements in lung cancer diagnosis for tumor heterogeneity, mutational analysis and targeted therapies: initial experience with intra-operative Frozen Section Evaluation (FROSE) in bronchoscopic biopsies
- (2016) Jeffrey S. Iding et al. Journal of Thoracic Disease
- Driver and Passenger Mutations in Cancer
- (2015) Julia R. Pon et al. Annual Review of Pathology-Mechanisms of Disease
- ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non-Small Cell Lung Cancer
- (2015) R. Govindan et al. CLINICAL CANCER RESEARCH
- The Precision Medicine Initiative
- (2015) Euan A. Ashley JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
- (2015) Christophe Le Tourneau et al. LANCET ONCOLOGY
- The Brave New World of clinical cancer research: Adaptive biomarker-driven trials integrating clinical practice with clinical research
- (2015) Donald A. Berry Molecular Oncology
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations
- (2015) David M. Hyman et al. NEW ENGLAND JOURNAL OF MEDICINE
- A New Initiative on Precision Medicine
- (2015) Francis S. Collins et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Master Protocol Concept
- (2015) Mary W. Redman et al. SEMINARS IN ONCOLOGY
- FDA Approval Summary: Vemurafenib for Treatment of Unresectable or Metastatic Melanoma with the BRAFV600E Mutation
- (2014) G. Kim et al. CLINICAL CANCER RESEARCH
- FDA Approval: Ado-Trastuzumab Emtansine for the Treatment of Patients with HER2-Positive Metastatic Breast Cancer
- (2014) L. Amiri-Kordestani et al. CLINICAL CANCER RESEARCH
- Circulating Tumor DNA as a Liquid Biopsy for Cancer
- (2014) E. Heitzer et al. CLINICAL CHEMISTRY
- Precision Medicine Clinical Trials: Defining New Treatment Strategies
- (2014) Brandy M. Heckman-Stoddard et al. Seminars in Oncology Nursing
- ‘Master protocol’ aims to revamp cancer trials
- (2013) Heidi Ledford NATURE
- Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
- (2012) Sunil Verma et al. NEW ENGLAND JOURNAL OF MEDICINE
- Designing phase II trials in cancer: a systematic review and guidance
- (2011) S R Brown et al. BRITISH JOURNAL OF CANCER
- Phase II study of fulvestrant in recurrent/metastatic endometrial carcinoma: A Gynecologic Oncology Group Study
- (2010) Allan L. Covens et al. GYNECOLOGIC ONCOLOGY
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started